Skip to content

Clinical trials

Phase 2 Autism Spectrum Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Phase 2 Clear all

148 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20064
20072
20081
20093
20105
20116
20128
20138
20149
20155
20168
20174
201810
20198
202011
20219
20227
202312
20249
202513
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed77
Recruiting23
Terminated13
Withdrawn10
Active, not recruiting10
Unknown status8
Not yet recruiting5
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Holland Bloorview Kids Rehabilitation Hospital9
Stanford University8
Massachusetts General Hospital5
Evdokia Anagnostou4
National Institute of Mental Health (NIMH)4
Southwest Autism Research & Resource Center4
Assistance Publique - Hôpitaux de Paris3
Forest Laboratories3
Hoffmann-La Roche3
Jazz Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder148
Autistic Disorder59
Anxiety Disorders9
Asperger Syndrome9
Child Development Disorders, Pervasive8
Attention Deficit Disorder with Hyperactivity3
Developmental Disabilities3
Fragile X Syndrome3
Language Disorders3
Neurodevelopmental Disorders3

Trials

Showing 26 to 50 of 148. Each trial links to its page on Pharma Observatory.

48 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.